Perspective Therapeutics Ratios (2010-2026) | CATX

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Ratios	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026
Profitability
Gross Margin (Quarter)	49.67%	40.13%	43.32%	49.52%	36.97%	24.11%		26.61%	16.53%	33.78%	0.80%
EBT Margin (Quarter)	49.67%	-87.48%	-56.96%	-46.29%	-82.95%	-236.92%		-594.04%	-740.40%	-473.96%	158.57%
EBIT Margin (Quarter)	49.67%	-88.69%	-58.06%	-47.29%	-84.07%	-245.08%		-533.39%	-650.27%	-446.22%	238.19%
EBITDA Margin (Quarter)	49.67%	-88.69%	-58.06%	-47.29%	-84.07%	-245.08%		-533.39%	-650.27%	-446.22%	238.19%
Operating Margin (Quarter)	49.67%	-88.69%	-58.06%	-47.29%	-84.07%	-245.08%		-533.39%	-650.27%	-446.22%	238.19%
Net Margin (Quarter)	-39.15%	-87.48%	-56.96%	-46.29%	-82.95%	-236.92%		-80.11%	-108.00%	-35.88%	105.73%
FCF Margin (Quarter)		-83.39%	98.26%	-49.83%	-177.49%	-107.92%		-542.30%	-525.93%	-506.86%	185.58%
Efficiency
Inventory Average (Quarter)	0.86M	1.02M	1.06M	1.12M	1.28M	1.47M	1.48M	1.41M	1.25M	1.05M
Assets Average (Quarter)	70.85M	69.56M	67.98M	66.68M	65.28M	63.49M	60.31M	92.87M	123.89M	115.33M	104.20M	188.09M	332.10M	388.54M	366.13M	335.23M	320.04M	302.77M	280.90M	338.87M
Equity Average (Quarter)	67.75M	66.58M	65.08M	63.80M	62.24M	59.49M	56.17M	86.33M	113.34M	103.71M	86.97M	152.53M	285.44M	334.73M	309.57M	287.66M	275.17M	253.95M	224.62M	277.23M
Invested Capital (Quarter)	67.41M	65.76M	64.39M	63.20M	61.28M	57.70M	54.64M	118.03M	108.65M	98.77M	75.18M	229.89M	341.00M	328.47M	290.67M	284.64M	265.69M	242.22M	207.03M	347.44M
Asset Utilization Ratio (Quarter)	0.14	0.15	0.16	0.16	0.17	0.16		0.10	0.06	0.06	0.01
Leverage & Solvency
Interest Coverage Ratio (Quarter)								-542.28	-375.15	-696.43	-486.50	-448.45	-620.13	-270.06	616.22	-170.56	-202.01	-428.63	-622.38	-269.34
Debt to Equity (Quarter)								0.01	0.02	0.02	0.02	0.01	0.00	0.00	0.01	0.01	0.01	0.01	0.01	0.00
Debt Ratio (Quarter)								0.01	0.01	0.02	0.02	0.01	0.00	0.00	0.00	0.00	0.01	0.01	0.01	0.00
Equity Ratio (Quarter)	0.96	0.96	0.96	0.96	0.95	0.92	0.94	0.92	0.90	0.89	0.77	0.83	0.88	0.84	0.85	0.86	0.86	0.82	0.78	0.85
Times Interest Earned (Quarter)								-542.28	-375.15	-696.43	-486.50	-448.45	-620.13	-270.06	616.22	-170.56	-202.01	-428.63	-622.38	-269.34
Dividends & Payouts
FCF Payout Ratio (Quarter)
Valuation
Enterprise Value (Quarter)	-63.83M	-61.69M	-60.35M	-58.90M	-55.89M	-54.11M	-43.76M	-36.45M	-28.32M	-17.98M	-9.24M	-180.65M	-292.87M	-309.20M	-226.92M	-379.00M	-354.33M	-174.14M	-144.74M	-487.86M
Return Ratios
Return on Sales (Quarter)	0.00%	-0.01%	-0.01%	0.00%	-0.01%	-0.02%		-0.01%	-0.01%	0.00%	0.01%
Return on Capital Employed (Quarter)	-1.46%	-3.79%	-5.03%	-6.09%	-11.73%	-15.68%	-23.27%	-25.32%	-25.45%	-32.54%	-46.24%	-25.45%	-15.15%	-15.98%	-26.12%	-30.91%	-35.66%	-42.07%	-45.03%	-39.04%
Return on Invested Capital (Quarter)								0.00%	0.00%	0.00%
Return on Assets (Quarter)	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Equity (Quarter)	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Research Tools

Perspective Therapeutics Ratios (2010-2026) | CATX

Create an account

Sign In

Reset Password